Innovative Solutions for Drug Discovery and Development

USD 950.00

* Required Fields

USD 950.00


Be the first to review this product

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across novel methods that improve drug discovery. The service encompasses recent advances in drug discovery technologies that impact precision oncology, targeted cancer therapy, Big Data analytics and Parkinson’s disease management. Lastly, the TOE summarizes key technology trends that leverage stem cell platforms for advancing drug discovery.The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used f

Table of Contents

Innovative Solutions for Drug Discovery and DevelopmentDriving New Approaches To Enhance Drug DiscoveryBiofluorescence Platform for Early Cancer DetectionAdvanced Genome Analytics for Precision OncologyIntelligent Driven Therapeutics DiscoveryCancer Vaccines Advancing Clinical TrialsFirst FDA Approved Biosimilar for Treatment of Cancer FDA-approved Treatment for Parkinson’s Disease Associated Hallucinations and DelusionsDiscovery of Novel Anti-cancer TherapiesDrug DiscoveryTechnology Focus and TrendsTechnology Focus and TrendsCompanies to WatchIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.